The studies of Wang et al. showed that the growth-inhibitory effects of PPARγ agonist compounds on MM lines was seen only inlines expressing PPARγ and that these effects were reversed bycotreatment with an antagonist compound [31]. Here, PPARG is linked to Miyoshi myopathy.